Related Experiment Video

Updated: Apr 20, 2026

Oct4GiP Reporter Assay to Study Genes that Regulate Mouse Embryonic Stem Cell Maintenance and Self-renewal
08:01

Oct4GiP Reporter Assay to Study Genes that Regulate Mouse Embryonic Stem Cell Maintenance and Self-renewal

Published on: May 30, 2012

10.9K

Transcription factor decoy against stem cells master regulators, Nanog and Oct-4: a possible approach for

Seyed Mohammad Ali Hosseini Rad1, Taravat Bamdad, Majid Sadeghizadeh

  • 1Department of Virology, Faculty of Medical Sciences, Tarbiat Modares University, P.O. Box 14115-331, Tehran, Iran, a.hoseini.rad@gmail.com.

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|December 4, 2014
PubMed

Insights

Transcription factor decoys (TFDs) offer a novel approach to downregulate gene expression. This study demonstrates TFDs targeting stemness regulators like Nanog can reduce gene expression in cancer stem cells.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Stem Cell Biology

Background:

  • Cancer stem cells (CSCs) drive tumor growth and share properties with embryonic stem cells (ESCs).
  • Key transcription factors (TFs) like Nanog, Oct-4, Sox2, and Klf4 maintain stemness in both CSCs and ESCs.
  • Differentiation therapy aims to eliminate tumors by inducing CSC differentiation.

Purpose of the Study:

  • To investigate the efficacy of transcription factor decoys (TFDs) in downregulating stemness-associated genes.
  • To explore TFDs targeting master regulators Nanog, Oct-4, and Klf4 in P19 embryonic carcinoma stem cells.
  • To present the first report of a TFD approach against these specific stemness regulators.

Main Methods:

  • Design and synthesis of various simple and complex transcription factor decoys.
  • Application of TFDs to P19 embryonic carcinoma stem cells.
  • Assessment of gene expression changes following TFD treatment.

Main Results:

  • Successfully designed and applied TFDs against Nanog, Oct-4, Sox2, and Klf4.
  • Demonstrated that TFDs can effectively decrease the expression of target genes.
  • Observed a particularly significant downregulation of downstream genes with Nanog-specific decoys.

Conclusions:

  • Transcription factor decoys represent a promising strategy for targeting stemness pathways in cancer.
  • TFDs can specifically downregulate key regulators of stemness, offering potential therapeutic applications.
  • Nanog-specific decoys show notable efficacy in reducing gene expression, warranting further investigation.

More Related Videos

In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells11:37

In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells

Published on: February 18, 2015

14.3K
Profiling Individual Human Embryonic Stem Cells by Quantitative RT-PCR09:03

Profiling Individual Human Embryonic Stem Cells by Quantitative RT-PCR

Published on: May 29, 2014

12.2K

Related Concept Videos

Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
8.1K
Master Transcription Regulators02:23

Master Transcription Regulators

2.9K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.9K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.3K
Combinatorial Gene Control02:33

Combinatorial Gene Control

Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
10.5K
Maintenance of the ES Cell State01:14

Maintenance of the ES Cell State

The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...
2.8K